Association analysis of the lymphocyte-specific protein tyrosine kinase (LCK) gene in type 1 diabetes

Diabetes. 2004 Sep;53(9):2479-82. doi: 10.2337/diabetes.53.9.2479.

Abstract

Prior data associating the expression of lymphocyte-specific protein tyrosine kinase (LCK) with type 1 diabetes, its critical function in lymphocytes, and the linkage of the region to diabetes in the nonobese diabetic (NOD) mouse model make LCK a premier candidate for a susceptibility gene. Resequencing of LCK in 32 individuals detected seven single nucleotide polymorphisms (SNPs) with allele frequencies >3%, including four common SNPs previously reported. These and six other SNPs from dbSNP were genotyped in a two-stage strategy using 2,430 families and were all shown not to be significantly associated with type 1 diabetes. We conclude that a major role for the common LCK polymorphisms in type 1 diabetes is unlikely. However, we cannot rule out the possibility of there being a causal variant outside the exonic, intronic, and untranslated regions studied.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Child
  • Diabetes Mellitus, Type 1 / genetics*
  • Genetic Predisposition to Disease
  • Genotype
  • Humans
  • Lymphocyte Specific Protein Tyrosine Kinase p56(lck) / genetics*
  • Polymorphism, Single Nucleotide

Substances

  • Lymphocyte Specific Protein Tyrosine Kinase p56(lck)